Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease

被引：1
|
作者：
Abreu, MT [1 ]
机构：
[1] CUNY Mt Sinai Sch Med, Ctr Inflammatory Bowel Dis, New York, NY 10029 USA
来源：
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2005年 / 2卷 / 05期
关键词：
bone mineral density; budesonide; corticosteroids; Crohn's disease; osteoporosis;
D O I：
10.1038/ncpgasthep0173
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：210 / 211
页数：2
相关论文
共 50 条
  • [21] Effect of mineral status and glucocorticoid use on bone mineral density in patients with Crohn's disease
    Pierote, Nayane R.
    Braz, Amanda F.
    Barros, Susy L.
    Moita Neto, Jose M.
    Parente, Jose Miguel L.
    Silva, Maria da Cruz M.
    Beserra, Mayara S.
    Soares, Nina Rosa M.
    Marreiro, Dilina N.
    Nogueira, Nadir do Noscimento
    NUTRITION, 2018, 48 : 13 - 17
  • [22] Bones and Crohn's - Risk factors associated with low bone mineral density in patients with Crohn's disease
    Siffledeen, JS
    Fedorak, RN
    Siminoski, K
    Jen, H
    Vaudan, E
    Abraham, N
    Seinhart, H
    Greenberg, G
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (03) : 220 - 228
  • [23] Low bone mineral density in children with Crohn's disease
    Bourges, O
    Dorgeret, S
    Alberti, C
    Hugot, JP
    Sebag, G
    Cézard, JP
    ARCHIVES DE PEDIATRIE, 2004, 11 (07): : 800 - 806
  • [24] Budesonide controlled ileal release (CIR) capsules in prednisolone-dependent patients with Crohn's disease
    Cortot, A
    Colombel, JF
    Rutgeerts, P
    Lauritsen, K
    Malchow, H
    Hamling, J
    Winter, T
    Pallant, D
    Pettersson, E
    GASTROENTEROLOGY, 1999, 116 (04) : A692 - A693
  • [25] Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's disease
    Lundin, P
    Naber, T
    Nilsson, M
    Edsbäcker, S
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) : 45 - 51
  • [26] Treatment of joint pain in Crohn's patients with budesonide controlled ileal release
    Florin, THJ
    Graffner, H
    Nilsson, LG
    Persson, T
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (04) : 295 - 298
  • [27] Increase of bone mineral density with sodium fluoride in patients with Crohn's disease.
    Von Tirpitz, C
    Klaus, J
    Brückel, J
    Rieber, A
    Böhm, BO
    Adler, G
    Reinshagen, M
    GASTROENTEROLOGY, 1998, 114 (04) : A1112 - A1112
  • [28] What nutritional factors influence bone mineral density in Crohn's disease patients?
    Coqueiro, Fernanda Gomes
    Rocha, Raquel
    Menezes, Camilla Almeida
    Lopes, Mirella Brasil
    Oliveira, Vanessa Rosa
    Lorenzo Fortes, Flora Maria
    Santana, Genoile Oliveira
    INTESTINAL RESEARCH, 2018, 16 (03) : 436 - 444
  • [29] Bone mineral density & risk factors for osteoporosis in patients with Crohn's disease.
    Bartram, SA
    Hainsworth, PJ
    Mansfield, J
    Peaston, R
    Francis, RM
    Walshaw, D
    Thompson, NP
    GASTROENTEROLOGY, 2000, 118 (04) : A316 - A316
  • [30] Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
    Haderslev, KV
    Tjellesen, L
    Sorensen, HA
    Staun, M
    GASTROENTEROLOGY, 2000, 119 (03) : 639 - 646
12345